MindBio Therapeutics Develops AI-Driven Fatigue Detection Model for High-Risk Workplaces

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company commercializing AI-driven voice technology for drug and alcohol intoxication detection, is broadening its platform with the development of a fatigue prediction model designed for high-risk workplace environments. The announcement reflects a broader strategy by MindBio to position voice analytics as a scalable alternative to conventional impairment screening methods such as breathalyzers, saliva tests, urine analysis and laboratory-based toxicology testing.

The fatigue detection capability is expected to become an additional feature within MindBio’s planned Edge AI Intoxication Detection Kiosks, which are being designed to identify signs of alcohol, drug impairment and fatigue from short voice samples. Rather than relying on physical samples, the company’s platform analyzes speech characteristics captured through a microphone and processes the audio using machine learning models trained on large voice datasets.

MindBio’s AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.

The expansion into fatigue detection underscores the potential of voice analytics to address multiple safety challenges in industries where impairment—whether from substances or exhaustion—can lead to catastrophic accidents. According to the National Safety Council, fatigue-related incidents cost U.S. employers an estimated $136 billion annually in health-related lost productivity, and the issue is particularly acute in sectors like mining and construction, where long shifts and demanding physical labor are common.

MindBio’s approach could offer a non-invasive, rapid screening tool that complements existing safety protocols. The company’s kiosks are being designed for deployment at entry points to worksites, allowing for quick checks without the need for specialized personnel or laboratory analysis. This could reduce downtime and improve compliance compared to traditional methods.

The announcement comes as regulatory and industry interest in fatigue management grows. The U.S. Mine Safety and Health Administration has increasingly emphasized the role of fatigue in mining accidents, and the Federal Aviation Administration has long recognized fatigue as a critical safety risk among pilots and maintenance crews.

For investors, MindBio’s progress in voice analytics represents a bet on the convergence of artificial intelligence and occupational safety. The company’s technology, if validated in field trials, could tap into a market that includes not only the industries it currently targets but also transportation, healthcare and public safety. However, the path to widespread adoption will require regulatory approval, partnerships with major employers, and demonstration of reliability across diverse populations and conditions.

The full article detailing MindBio’s fatigue prediction model is available at https://nnw.fm/5DDUT. More information about the company is available in its newsroom at https://nnw.fm/MBQIF.

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is MindBio Therapeutics Develops AI-Driven Fatigue Detection Model for High-Risk Workplaces.

The post MindBio Therapeutics Develops AI-Driven Fatigue Detection Model for High-Risk Workplaces appeared first on citybuzz.